Isansys CEO Keith Errey to present at Biotech Investment Showcase

Isansys CEO Keith Errey to present at Biotech Investment Showcase

Event date 22 May 2018 09:00 – 23 May 2018 18:00

Location De Vere Grand Connaught Rooms 61-65 Great Queen St London WC2B 5DA

The 2018 Biotech Investment showcase is the UK and Europe’s most focussed and leading-edge funding, investment and partnering forum in the biotech sector, hosting over 200 attendees.

Leading VC funds, investors, hedge funds, emerging successful biotech spinoffs, early stage biotech discovery and clinical companies and KOLs in the sector will be attending this one of a kind showcase event on the 22nd & 23rd May 2018 in London. The event will help to identify key technological and scientific investment areas and offers a unique networking, partnering and business development opportunity for those involved.

Keith Errey will be speaking at 3pm-3.30pm on Day 1 about digital health. 

More details can be found here: https://www.biotechinvestment-showcase.com/ 

Contacts

Georgina Horton

Georgina Horton

Press contact Head of Communications 01235 436225

Providing extraordinary new digital medical tools to transform patient data into valuable clinical insight

Isansys provides remote monitoring solutions which improve patient care, drive clinical performance, ensure economic value and enhance patient safety.

Headquartered in Oxfordshire, with subsidiaries in Germany, India and the US, Isansys is a privately limited company which was founded in 2010 by Keith Errey and Rebecca Weir.

Our business is to work with health professionals, insurance companies and healthcare organisations to provide more efficient patient monitoring against a backdrop of staff shortages and a rising number of patients and costs and limited budgets.

All our products and devices are fully certified and qualified medical devices.

Isansys
8C Park Square
OX14 4RR Oxford
United Kingdom
Privacy Policy
Privacy Policy for Contacts
Cookie Policy
Isansys Homepage